Open Access
| Issue |
BIO Web Conf.
Volume 184, 2025
The 3rd International Seminar of the Indonesian Society for Biochemistry and Molecular Biology (ISISBMB 2025)
|
|
|---|---|---|
| Article Number | 04001 | |
| Number of page(s) | 7 | |
| Section | Cross-Disciplinary Synergies | |
| DOI | https://doi.org/10.1051/bioconf/202518404001 | |
| Published online | 12 August 2025 | |
- N. S. Arden, A. C. Fisher, K. Tyner, L. X. Yu, S. L. Lee, and M. Kopcha, Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future, Int. J. Pharm. 602, 120554 (2021). https://doi.org/10.1016/j.ijpharm.2021.120554. [Google Scholar]
- O. O. Ogbuagu, A. O. Mbata, O. D. Balogun, O. Oladapo, O. O. Ojo, and M. Muonde, Quality assurance in pharmaceutical manufacturing: Bridging the gap between regulations, supply chain, and innovations, Int. J. Multidiscip. Res. Growth Eval. 4, 823 (2023). https://doi.org/10.54660/.IJMRGE.2023.4.1-823-831. [Google Scholar]
- BPOM, Peraturan Badan Pengawas Obat dan Makanan Nomor 25 Tahun 2021 Tentang Cara Pembuatan Obat Tradisional yang Baik (The Indonesian FDA Regulation Number 25 of 2021 concerning Good Traditional Medicine Manufacturing Methods) (2021) [In Indonesia]. [Google Scholar]
- BPOM, Peraturan Badan Pengawas Obat dan Makanan Nomor 24 Tahun 2023 tentang Persyaratan Keamanan dan Mutu Suplemen Kesehatan (The Indonesian FDA Regulation Number 24 of 2023 on Safety and Quality Requirements for Health Supplements) (2023) [In Indonesia]. [Google Scholar]
- T. S. Jan, T. Handayani, and M. Sueb, Supervision and registration of traditional medicine brands in Indonesia, Nagari Law Rev. 5, 87 (2021). http://doi.org/10.25077/nalrev.v.5.i.1.p.87-92.2021. [Google Scholar]
- I. A. Adeniran, A. O. Abhulimen, A. N. Obiki-Osafiele, O. S. Osundare, E. E. Agu, and C. P. Efunniyi, Strategic risk management in financial institutions: Ensuring robust regulatory compliance, Finance Account. Res. J. 6, 1582 (2024). http://doi.org/10.51594/farj.v6i8.1508. [Google Scholar]
- R. Mahanti, Data governance and compliance, in Data Governance and Compliance: Evolving to Our Current High Stakes Environment (Springer, Singapore, 2021), pp. 109-153. http://doi.org/10.1007/978-981-33-6877-4. [Google Scholar]
- BPOM, Peraturan Badan Pengawas Obat dan Makanan Nomor 25 Tahun 2023 Tentang Kriteria dan Tata Laksana Registrasi Obat Bahan Alam (The Indonesia FDA Regulation Number 25 of 2023 concerning Criteria and Procedures for Registration of Natural Medicines) (2023) [In Indonesia]. [Google Scholar]
- E. Etiaba, P. Agwu, L. Conteh, and O. Onwujekwe, Multisectoral contributions to health security and formal policy availability at the community level in Nigeria, Front. Public Health 13, 1505383 (2025). https://doi.org/10.3389/fpubh.2025.1505383. [Google Scholar]
- M. Jaberidoost, S. Nikfar, A. Abdollahiasl, and R. Dinarvand, Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process and simple additive weighting methods, J. Pharm. Policy Pract. 8, 9 (2015). https://doi.org/10.1186/s40545-015-0029-3. [Google Scholar]
- BPOM, Peraturan Badan Pengawas Obat dan Makanan Nomor 7 Tahun 2024 Tentang Standar Cara Pembuatan Obat yang Baik (2024) [The Indonesian FDA Regulation Number 7 of 2024 concerning Standards for Good Manufacturing Methods (2024) [In Indonesia]. [Google Scholar]
- BPOM, Peraturan Badan Pengawas Obat dan Makanan Nomor 6 Tahun 2020 Tentang Pedoman Teknis Cara Distribusi Obat yang Baik (2020) (The Indonesian FDA Regulation Number 6 of 2020 on Technical Guidelines for Good Drug Distribution Methods) (2020) [In Indonesia]. [Google Scholar]
- BPOM, Peraturan Badan Pengawas Obat dan Makanan Nomor 34 Tahun 2022 Tentang Pengawasan Periklanan Obat Tradisional, Obat Kuasi, dan Suplemen Kesehatan (The Indonesian FDA Regulation No. 34 of 2022 on the Supervision of Advertising of Traditional Medicines, Quasi-Medicines, and Health Supplements) (2022) [In Indonesia]. [Google Scholar]
- BPOM, Peraturan Badan Pengawas Obat dan Makanan Nomor 10 Tahun 2024 Tentang Penandaan Obat Bahan Alam, Obat Kuasi, dan Suplemen Kesehatan (The Indonesian FDA Regulation No. 10 of 2024 on the Marking of Natural Medicines, Quasi Medicines, and Health Supplements) (2024) [In Indonesia]. [Google Scholar]
- BPOM. Kegiatan Pengukuran Indeks Kepatuhan (Compliance Index) Pelaku Usaha di Bidang Obat dan Makanan Tahun 2024 [Compliance Index Measurement Activity for Business Actors in the Field of Medicines and Food, 2024] (2025) [In Indonesia]. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.